Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-03

Clinical Trial Update: Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating neutralizing antibodies and vaccination to induce HIV remission has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine | Conditions: HIV-1-infection | Phase 1 | Status: WITHDRAWN